Technical Service Need help? Our team of experienced experts is here for you with full support.
AKA-336
Validamycin A
Cat. No.
AKA-336
CAS No.
37248-47-8
MF
C20H35NO13
MW
497.49
Validamycin A is a fungicidal compound.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Service 
86-28-85159085 
info@aktin.com Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Validamycin A
CAS No.
37248-47-8
MF
C20H35NO13
MW
497.49
Specification
USP
Research Area
Validamycin A is an aminoglycoside antibiotic with bacteriostatic activity, serving as an agricultural antibacterial API and also having application value as a pharmaceutical intermediate, which acts on the carbohydrate metabolism of microorganisms.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Description
Validamycin A is a fungicidal compound. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g, 1kg Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store sealed, protected from light, at 2-8°C.
References
[1]. Napasawan Plabutong, et al. The Inhibitory Effect of Validamycin A on Aspergillus flavus. International Journal of Microbiology. 2020;2020:3972415.
[2]. N Asano, et al. Effect of validamycins on glycohydrolases of Rhizoctonia solani. J Antibiot (Tokyo). 1987 Apr;40(4):526-32.
[3]. Zhi-Jiang Wang, et al. The effect of validamycin A on tyrosinase: inhibition kinetics and computational simulation. International Journal of Biological Macromolecules. 2013 Apr;55:15-23.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
